You have 9 free searches left this month | for more free features.

Methyltestosterone

Showing 26 - 50 of 231

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urinary Incontinence, Menopause Trial (Testosterone Enanthate, Placebo)

Withdrawn
  • Urinary Incontinence
  • Menopause
  • Testosterone Enanthate
  • Placebo
  • (no location specified)
Jul 18, 2022

Testicular Cancer Trial in Groningen (Androgel (Testosterone gel), Placebo gel)

Recruiting
  • Testicular Cancer
  • Androgel (Testosterone gel)
  • Placebo gel
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 12, 2022

Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)

Recruiting
  • Prostate Cancer
  • Brasília, Distrito Federal, Brazil
  • +4 more
Dec 22, 2022

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Bone Metabolism Trial in Boston (testosterone cypionate)

Withdrawn
  • Bone Metabolism
  • testosterone cypionate
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 22, 2021

Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System Trial in Gainesville, Jacksonville (Testosterone Enanthate,

Recruiting
  • Spinal Cord Injury
  • +19 more
  • Testosterone Enanthate
  • Locomotor Training
  • Gainesville, Florida
  • +1 more
Aug 30, 2021

Testosterone Implants and the Incidence of Breast Cancer

Completed
  • Breast Cancer
  • Testosterone Implant
  • (no location specified)
Aug 30, 2021

Critical Illness Trial in Bordeaux, Clermont-Ferrand, La Roche-sur-Yon (Androgel Topical Product, Placebo, Physical performance)

Not yet recruiting
  • Critical Illness
  • Androgel Topical Product
  • +6 more
  • Bordeaux, France
  • +3 more
Apr 21, 2023

Hypogonadism, Male, Infertility, Male, Testosterone Deficiency Trial (Natesto Nasal Product)

Not yet recruiting
  • Hypogonadism, Male
  • +2 more
  • Natesto Nasal Product
  • (no location specified)
Jan 4, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2023

Healthy Aging, Age-Related Sarcopenia, Testosterone Deficiency Trial (Saline, Testosterone Undecanoate)

Not yet recruiting
  • Healthy Aging
  • +2 more
  • (no location specified)
Jul 19, 2023

Rotator Cuff Tears Trial in Sioux Falls (Testosterone cypionate, Placebos)

Withdrawn
  • Rotator Cuff Tears
  • Testosterone cypionate
  • Placebos
  • Sioux Falls, South Dakota
    Orthopedic Institute
Feb 28, 2022

Hypogonadism Trial in Denver (Acyline, Placebo Gel, Placebo Tablet)

Recruiting
  • Hypogonadism
  • Denver, Colorado
    University of Colorado CCTSI CTRC
Apr 25, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Androgen Suppression
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Jan 5, 2023

Spinal Cord Injuries Trial in Boston (Testosterone Undecanoate, hybrid exercise)

Recruiting
  • Spinal Cord Injuries
  • Testosterone Undecanoate
  • hybrid exercise
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 11, 2022

HIV, HIV Wasting Syndrome Trial in United States (Testosterone enanthate, Megestrol acetate)

Completed
  • HIV Infections
  • HIV Wasting Syndrome
  • Testosterone enanthate
  • Megestrol acetate
  • Los Angeles, California
  • +20 more
Oct 28, 2021

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Muscle Atrophy, ACL Reconstruction, Trauma Trial in Los Angeles (Testosterone, Placebo)

Completed
  • Muscle Atrophy
  • +3 more
  • Los Angeles, California
    University of Southern California
Feb 8, 2022

Boys With Pubertal Delay or Confirmed Hypogonadism

Recruiting
  • Delayed Puberty
  • Male Hypogonadism
  • Testosterone Undecanoate
  • Buenos Aires, Distrito Federal, Argentina
    Rodolfo Rey
Sep 12, 2022

Men With Low Testosterone Levels Trial in Culver City (Testosterone Enanthate, Placebo)

Completed
  • Men With Low Testosterone Levels
  • Testosterone Enanthate
  • Placebo
  • Culver City, California
    Urological Sciences Research Foundation
Apr 26, 2021

Diabetes Type 2 Trial in Buffalo (androgel, androgel 10g, )

Completed
  • Diabetes Mellitus Type 2
  • Buffalo, New York
    Diabetes-Endocrinology Center of Western NY, 115 flint road
Jan 14, 2022

Dyssocial Behavior Trial in Austin (testosterone propionate, 0.5% cholorbutanol, saline)

Completed
  • Dyssocial Behavior
  • testosterone propionate
  • 0.5% cholorbutanol, saline
  • Austin, Texas
    Robert Josephs
Apr 28, 2021

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

Recruiting
  • Prostate Cancer
  • +6 more
  • Radiotherapy (SBRT) and/or surgery (metastasectomy)
  • +2 more
  • Leuven, Belgium
    University Hospitals Leuven
Jun 7, 2022

Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Androgen deprivation therapy (ADT)
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center Seidman Cancer Cen
Nov 21, 2023

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Laboratory Biomarker Analysis
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 19, 2022